HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML
B. BRAUN MEDICAL INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML in Canada?
Not currently. The most recent shortage report for HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML 5000UNIT 410MG 93MG 5G is marked resolved (last updated June 30, 2026).
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
01935941
Strength
5000UNIT 410MG 93MG 5G
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
HEPARIN SODIUM SODIUM PHOSPHATE DIBASIC CITRIC ACID DEXTROSE
Tier
Unrated
Last Updated
2026-06-30
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from B. BRAUN MEDICAL INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 01931598
4.5MG · DIN 01927949
0.9% · DIN 01924303
100MG · DIN 01924427
DIN 01927531
DIN 01924435
50MG · DIN 01924281
5G · DIN 01928007
DIN 02209713
DIN 02209721
DIN 01931628
DIN 01931679